Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sanofi (SNY) Net Margin (2016 - 2026)

Sanofi's Net Margin history spans 16 years, with the latest figure at 0.25% for Q1 2026.

  • On a quarterly basis, Net Margin fell 151.0% to 0.25% in Q1 2026 year-over-year; TTM through Mar 2026 was 6.03%, a 582.0% increase, with the full-year FY2025 number at 17.91%, up 437.0% from a year prior.
  • Net Margin hit 0.25% in Q1 2026 for Sanofi, down from 33.4% in the prior quarter.
  • Over the last five years, Net Margin for SNY hit a ceiling of 109.22% in Q4 2022 and a floor of 2.77% in Q4 2024.
  • Historically, Net Margin has averaged 20.03% across 5 years, with a median of 16.77% in 2022.
  • Biggest five-year swings in Net Margin: surged 10669bps in 2022 and later tumbled -11024bps in 2023.
  • Tracing SNY's Net Margin over 5 years: stood at 109.22% in 2022, then plummeted by -101bps to 1.02% in 2023, then crashed by -171bps to 2.77% in 2024, then surged by 1307bps to 33.4% in 2025, then plummeted by -99bps to 0.25% in 2026.
  • Business Quant data shows Net Margin for SNY at 0.25% in Q1 2026, 33.4% in Q4 2025, and 8.85% in Q3 2025.